GassnerHG, SherrisDA. Chemoimmobilization: improving predictability in the treatment of facial scars.. Plast Reconstr Surg. 2003; 112(5):1464–1466 14504533
4.
ChoiJC, LucarelliMJ, ShoreJW. Use of botulinum A toxin in patients at risk of wound complications following eyelid reconstruction.. Ophthal Plast Reconstr Surg. 1997; 13(4):259–264 9430303
5.
ZimblerMS, HoldsJB, KokoskaMS, et al.. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial.. Arch Facial Plast Surg. 2001; 3(3):165–169 11497500
6.
TollefsonTT, SendersCM, SykesJM, ByorthPJ. Botulinum toxin to improve results in cleft lip repair.. Arch Facial Plast Surg. 2006; 8(3):221–222 16702537
7.
CarruthersJ, FagienS, MatarassoSL. Botox Consensus Group. Consensus recommendations on the use of botulinum toxin A in facial aesthetics.. Plast Reconstr Surg. 2004; 114(6)(suppl)1S–22S 15507786
8.
MatarassoSL, MatarassoA. Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytids.. Plast Reconstr Surg. 2001; 108(1):208–217 11420526
9.
GassnerHG, SherrisDA. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study.. Mayo Clin Proc. 2000; 75(7):701–704 10907385